Behcet’s disease and severe inflammatory reaction to 23-valent pneumococcal polysaccharide vaccine: a case report and review of literature
2018 ◽
Vol 63
(4)
◽
pp. 119-121
◽
Keyword(s):
Current European League Against Rheumatism guidelines strongly recommend considering the use of polysaccharide pneumococcal vaccine in all patients with autoimmune inflammatory rheumatic diseases. However, a previously published case series reports of reactions to 23-valent pneumococcal polysaccharide vaccine in patients with Behcet’s disease. The purpose of this report is to present a similar case of a systemic adverse reaction in a patient with Behcet’s disease to 23-valent pneumococcal polysaccharide vaccine.
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 54
(6)
◽
pp. 494-498
Keyword(s):
Keyword(s):
2016 ◽
Vol 15
(4)
◽
pp. 375-378
◽
2009 ◽
Vol 49
(3)
◽
pp. 467-470
◽
2017 ◽
Vol 255
(10)
◽
pp. 2017-2021
◽
Keyword(s):
Keyword(s):